Myograf (filgrastim biosimilar)
/ Amgen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 24, 2026
Clinical Safety Evaluation and Preliminary Efficacy Study of Subcutaneous Myografts Transplantation
(clinicaltrials.gov)
- P1 | N=6 | Not yet recruiting | Sponsor: National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China
New P1 trial • Metabolic Disorders • Transplantation
1 to 1
Of
1
Go to page
1